Key result
Maternal obesity was associated with a higher risk of adverse outcomes including preeclampsia (aOR 2.199; 95% CI 1.46-3.29) and cesarean section (aOR 2.755; 95% CI 2.46-3.08) compared to normal weight.
Why the study?
Obesity in pregnancy is increasing worldwide and frequently creates challenges for obstetricians, prompting an assessment of its effects on maternal and perinatal outcomes.
Does maternal obesity increase the risk of adverse obstetric, perinatal, and neonatal outcomes in women delivering singleton babies?
Cohort (n=16,609)
Does maternal obesity increase the risk of adverse obstetric, perinatal, and neonatal outcomes in women delivering singleton babies?
Effect estimate: aOR 2.199 (95% CI 1.46-3.29)
Maternal obesity is associated with a significantly higher risk of adverse pregnancy and perinatal outcomes, including preeclampsia and cesarean delivery.
May inform closer monitoring in obese pregnancies; extends Level 3 evidence without establishing causality.
Background Obesity in pregnancy is increasing worldwide, reaching epidemic proportions in many countries and frequently creating challenges for obstetricians. We conducted this study to assess the effects of maternal obesity on maternal and perinatal outcomes. Methods A historical cohort study was performed on 16,609 women who delivered singleton babies in a 5-year period (2013-2017). Data were retrieved from the Cruces Perinatal Database (CPD) and only women whose prepregnancy body mass index (BMI) was known were included. Women were categorized according to the World Health Organization (WHO) classification: normal weight (BMI 20-24.9 kg/m2) and obesity (BMI ≥ 30 kg/m2). Obstetric, perinatal and neonatal outcomes were compared, and adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) were calculated using the normal-weight group as the reference. Results Compared to women of normal weight (n = 9778), obese women (n = 2207) had a higher risk of preeclampsia (aOR 2.199, 95% CI: 1.46-3.29), rectovaginal group B streptococcus colonization (aOR 1.299, 95% CI: 1.14-1.47), induction of labor (aOR 1.593, 95% CI: 1.44-1.75), cesarean section (aOR 2.755, 95% CI: 2.46-3.08), cesarean section in women with a history of cesarean delivery (aOR 1.409, 95% CI: 1.03-1.92), fetal weight ≥4000 g (aOR 2.090, 95% CI: 1.803-2.422) and admission to the neonatal intensive care unit (NICU) (aOR 1.341, 95% CI: 1.12-1.59). No association was found with preterm birth (aOR 0.936, 95% CI: 0.77-1.13), stillbirth (aOR 0.921, 95% CI: 0.41-2.02) or neonatal mortality (aOR 2.205, 95% CI: 0.86-5.62). Conclusion Maternal obesity is associated with a higher risk of adverse pregnancy and perinatal outcomes. Pregnancy in this population of women should be considered and managed as high risk.
No takes yet. Share an insight, caveat, or question.
Corcóstegui et al. (2019) conducted a cohort in Pregnancy (n=16,609). Maternal obesity (BMI ≥ 30 kg/m2) vs. Normal weight (BMI 20-24.9 kg/m2) was evaluated on Preeclampsia (aOR 2.199, 95% CI 1.46-3.29). Maternal obesity was associated with a higher risk of adverse outcomes including preeclampsia (aOR 2.199; 95% CI 1.46-3.29) and cesarean section (aOR 2.755; 95% CI 2.46-3.08) compared to normal weight.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: